This inventor holds 2 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Other. Active years: 2000-2001.
Company Filing History:
1 out of 2,198 
1 out of 834,411 Years Active: 2000-2001
Title: Mark M Bouzyk: Innovator in Serum Inducible Kinase Research
Introduction
Mark M Bouzyk is a notable inventor based in Little Hadham, GB. He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides and polynucleotides related to serum inducible kinase (Snk). With a total of 2 patents, his work has implications for therapeutic and diagnostic applications.
Latest Patents
Bouzyk's latest patents focus on the Serum Inducible Kinase (Snk) polypeptides and polynucleotides. These patents disclose methods for producing such polypeptides through recombinant techniques. Additionally, they outline methods for utilizing Snk polypeptides and polynucleotides in therapy, as well as in diagnostic assays.
Career Highlights
Throughout his career, Bouzyk has worked with prominent organizations, including SmithKline Beecham Corporation. His experience in these companies has allowed him to refine his expertise in biochemistry and innovation.
Collaborations
Some of his notable coworkers include Karen M Anderson and Michael Joseph Hansbury. Their collaborative efforts have contributed to advancements in the field of serum inducible kinase research.
Conclusion
Mark M Bouzyk's innovative work in serum inducible kinase research highlights his role as a significant inventor in the biochemistry field. His patents and collaborations continue to influence therapeutic and diagnostic methodologies.